Prevalence of colonization and mitochondrial large subunit rRNA mutation of Pneumocystis jiroveci among Iranian children
,
Abstract
Background and Objectives: Pneumocystis jiroveci is an important causative agent of Pneumocystis pneumonia. During childhood, exposure to Pneumocystis occurs and antibody was built in early childhood. The aim of this study was to describe the molecular epidemiology of P. jiroveci in children without any respiratory syndrome and survey the distribution of different mitochondrial large subunit, ribosomal ribonucleic acid (mtLSU- rRNA) genotypes.
Materials and Methods: Mini-bronchoalveolar lavage (mini-BAL) fluids from pediatric patients with no history of lung disorders were obtained during a 14-month period. P. jiroveci colonization was confirmed by immunofluorescence staining, nested PCR and sequencing. Genotypic characterization at the mitochondrial large subunit rRNA gene was performed by direct sequencing.
Results: Of 172 BAL specimens from patients, with mean age of 4.9 years, the prevalence of P. jiroveci colonization was 3.5% (6 samples). The results of sequencing revealed the two polymorphisms; 85/A; 248/C in 3 cases, and 85/T; 248/C in other cases. One sample also showed a mutation replacement at position 258 (T-to-C change), which was not reported previously.
Conclusion: Colonized person as an environmental reservoir might play an important role in the progression of infection in immunocompromised patients. Diagnosis of the reservoir and genotyping can be essential for the prevention of nosocomial infections.
Peters SE, Wakefield AE, Sinclair K, Millard PR, Hop- kin JM. A search for Pneumocystis carinii in post-mor- tem lungs by DNA amplification. J Pathol 1992;166:195-198.
Pifer LL, Hughes WT, Stagno S, Woods D. Pneumo- cystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics 1978; 61:35–41.
Vargas SL, Hughes WT, Santolaya ME, Ulloa AV, Ponce CA, Cabrera CE, et al. Search for primary in- fection by Pneumocystis carinii a cohort of normal, healthy infants. Clin Infect Dis 2001; 32:855–861.
Respaldiza N, Medrano FJ, Medrano AC, Varela JM, De La Horra C, Montes-Cano M, et al. High seroprev- alence of Pneumocystis infection in Spanish children. Clin Microbiol Infect 2004 Nov;10(11):1029-31.
Medrano FJ, Montes-Cano M, Conde M, de la Horra C, Respaldiza N, Gasch A, et al. Pneumocystis jiroveci in general population. Emerg Infect Dis 2005; 11:245-250.
Rabodonirina M, Raffenot D, Cotte L, Boibieux A, Mayencon M, Bayle G, et al. Rapid detection of Pneu- mocystis carinii in bronchoalveolar lavage specimens from human immunodeficiency virus-infected pa-tients: use of a simple DNA extraction procedure and nested PCR. J Clin Microbiol 1997; 35:2748-2751.
Esteves F, Gaspar J, De Sousa B, Antunes F, Man- sinho K, Matos O. Clinical relevance of multiple single-nucleotide polymorphisms in Pneumocys- tis jiroveci Pneumonia: development of a multiplex PCR-single-base-extension methodology. J Clin Mi- crobiol 2011; 49:1810-1815.
Helweg-Larsen J, Tsolaki AG, Miller RF, Lundgren B, Wakefield AE. Clusters of Pneumocystis carinii pneu- monia: analysis of person-to-person transmission by genotyping. QJM 1998; 91:813-820.
Beard CB, Roux P, Nevez G, Hauser PM, Kovacs JA, Unnasch TR, et al. Strain typing methods and molecu- lar epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 2004; 10:1729-1735.
Beard CB, Carter JL, Keely SP, Huang L, Pieniazek NJ, Moura IN, et al. Genetic variation in Pneumocys- tis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis 2000;6:265-272.
Wakefield AE, Pixley FJ, Banerji S, Sinclair K, Miller RF, Moxon ER, et al. Detection of Pneumocystis carinii with DNA amplification. Lancet 1990;336:451–453.
Sinclair K, Wakefield AE, Banerji S, Hopkin JM. Pneu- mocystis carinii organisms derived from rat and human hosts are genetically distinct. Mol Biochem Parasitol 1991; 45:183-184.
Broaddus C, Dake MD, Stulbarg MS, Blumenfeld W, Hadley WK, Golden JA, et al. Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmo-nary infections in the acquired immunodeficiency syn- drome. Ann Intern Med 1985;102:747-752.
Miller RF, Ambrose HE, Novelli V, Wakefield AE.Probable mother-to-infant transmission of Pneumo- cystis carinii .sp. Hominis infection. J Clin Microbiol 2002; 40:1555 –1557.
Nevez G, Totet A, Pautard JC, Raccurt C. Pneumocystis carinii detection using nested-PCR in nasopharyngeal aspirates of immunocompetent infants with bronchiol- itis. J Eukaryot Microbiol 2001; Suppl:122S–123S.
Spencer L, Ukwu M, Alexander T, Valadez K, Liu L, Frederick T, et al. Epidemiology of Pneumocystis col- onization in families. Clin Infect Dis 2008; 46:1237–1240.
Shankar SM, Nania JJ. Management of Pneumocystis jiroveci pneumonia in children receiving chemothera- py. Paediatr Drugs 2007; 9: 301-309.
Durand-Joly I, Chabe M, Soula F, Delhaes L, Camus D, Dei-Cas E. Molecular diagnosis of Pneumocystis pneu- monia. FEMS Immunol Med Microbiol 2005; 45:405-410.
Respaldiza N, Montes-Cano MA, Dapena FJ, de la Horra C, Mateos I, Medrano FJ, et al. Prevalence of col- onization and genotypic characterization of Pneumo- cystis jiroveci among cystic fibrosis patients in Spain. Clin Microbiol Infect 2005; 11:1012-1015.
Pederiva MA, Wissmann G, Friaza V, Morilla R, de La Horra C, Montes-Cano MA, et al. High prevalence of Pneumocystis jiroveci colonization in Brazilian cystic fibrosis patients. Med Mycol 2012; 50:556-560.
| Files | ||
| Issue | Vol 8 No 5 (2016) | |
| Section | Articles | |
| Keywords | ||
| Keywords Pneumocystis jiroveci PCR genotypic pediatrics | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
